Von der molekularen Medizin bis zur Naturheilkunde^[1]

„Der Patient steht im Mittelpunkt“, dies ist einer der Leitsätze von Herrn Professor Blum, der seinen Tag in den frühen Morgenstunden mit einer Visite begann und am späten Abend mit einer Visite beendete. Seine Patienten begleitet er mit Bescheidenheit, Güte und unendlichem Wohlwollen; seine Schüler lehrte er, dass im Spannungsbogen zwischen Klinik, Wissenschaft und Ökonomie stets die Interessen des Patienten im Vordergrund stehen. Im folgenden Beitrag werden einige Schwerpunkte des vielseitigen Schaffens von Hubert E. Blum exemplarisch dargestellt.

Schlüsselwörter

Molekulare Medizin - Hepatologie - Infektiologie - Naturheilkunde - Palliativmedizin

Key words

molecular medicine - hepatology - infectious diseases - naturopathy - palliative care

¹ Gewidmet Herrn Prof. Dr. Dr. h. c. mult. Hubert E. Blum anlässlich seiner Verabschiedung als DMW-Herausgeber

• Literatur

• 1 Allgaier HP, Deibert P, Olschewski M. et al. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection – a single-center analysis including 132 patients. Int J Cancer 1998; 79: 601-605
• 2 Allgaier HP, Deibert P, Zuber I. et al. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 1999; 353: 1676-1677
• 3 Baumert TF, Rosler C, Malim MH. et al. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 2007; 46: 682-689
• 4 Baumert TF, Yang C, Schurmann P. et al. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes. Hepatology 2005; 41: 247-256
• 5 Becker G, Allgaier HP, Olschewski M. et al. Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study. Hepatology 2007; 45: 9-15
• 6 Bettinger D, Schultheiss M, Knuppel E. et al. Diarrhea predicts a positive response to sorafenib in patients with advanced hepatocellular carcinoma. Hepatology 2012; 56: 789-790
• 7 Blum HE, Galun E, Liang TJ. et al. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991; 65: 1836-1842
• 8 Blum HE, Galun E, von Weizsacker F. et al. Inhibition of hepatitis B virus by antisense oligodeoxynucleotides. Lancet 1991; 337: 1230
• 9 Blum HE, Haase AT, Harris JD. et al. Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology 1984; 139: 87-96
• 10 Blum HE, Vyas GN. Hepatitis B virus in non-hepatocytes. Lancet 1983; 2: 920
• 11 Blum HE, Zhang ZS, Galun E. et al. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol 1992; 66: 1223-1227
• 12 Borde JP, Dobler G, Rieg S. Update on Tick-Borne Diseases in Germany. Dtsch Med Wochenschr 2017; 142: 805-810
• 13 Brass V, Berke JM, Montserret R. et al. Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3–4A complex. Proc Natl Acad Sci U S A 2008; 105: 14545-14550
• 14 Dazert E, Neumann-Haefelin C, Bressanelli S. et al. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. J Clin Invest 2009; 119: 376-386
• 15 Dollinger MM, Lautenschlaeger C, Lesske J. et al. Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial. BMC Cancer 2010; 10: 457
• 16 Esser S, Rieg S. Syphilis und gonorrhoea--sexually transmitted infections of the past?. Dtsch Med Wochenschr 2012; 137: 1560-1564
• 17 Fatkenheuer G, Kern WV, Salzberger B. An urgent call for infectious diseases specialists. Infection 2016; 44: 269-270
• 18 Geissler M, Mohr L, Weth R. et al. Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice. Gastroenterology 2001; 121: 931-939
• 19 Grundemann C, Thell K, Lengen K. et al. Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism. PLoS One 2013; 8: e68016
• 20 Haberstroh A, Schnober EK, Zeisel MB. et al. Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion. Gastroenterology 2008; 135: 1719-1728
• 21 Hasegawa K, Huang J, Rogers SA. et al. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 1994; 68: 1651-1659
• 22 Huber R, Hockenjos B, Blum HE. DDB treatment of patients with chronic hepatitis. Hepatology 2004; 39: 1732-1733
• 23 Kern WV. Bacteraemia and sepsis. Dtsch Med Wochenschr 2011; 136: 182-185
• 24 Kern WV, Dettenkofer M. Nosocomial infections: MRSA und CDAD as a challenge. Internist (Berl) 2009; 50: 691-703
• 25 Kern WV, Wagner D, Hirsch HH. Infections after organ transplantation. Internist (Berl) 2005; 46: 630-642
• 26 Kock J, Baumert TF, Delaney WE. et al. Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes. Hepatology 2003; 38: 1410-1418
• 27 Lencioni RA, Allgaier HP, Cioni D. et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240
• 28 Offensperger WB, Offensperger S, Walter E. et al. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J 1993; 12: 1257-1262
• 29 Pestka JM, Zeisel MB, Blaser E. et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A 2007; 104: 6025-6030
• 30 Pichler C, Buchsel M, Rossen JW. et al. First report of invasive liver abscess syndrome with endophthalmitis caused by a K2 serotype ST2398 hypervirulent Klebsiella pneumoniae in Germany, 2016. New Microbes New Infect 2017; 17: 77-80
• 31 Rosler C, Kock J, Kann M. et al. APOBEC-mediated interference with hepadnavirus production. Hepatology 2005; 42: 301-309
• 32 Rosler C, Kock J, Malim MH. et al. Comment on “Inhibition of hepatitis B virus replication by APOBEC3G”. Science 2004; 305: 1403
• 33 Rossi S, Garbagnati F, Lencioni R. et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217: 119-126
• 34 Seigel B, Bengsch B, Lohmann V. et al. Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo. Gastroenterology 2013; 144: 426-436
• 35 Spangenberg HC, Thimme R, Blum HE. Targeted therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2009; 6: 423-432
• 36 Steinborn C, Klemd AM, Sanchez-Campillo AS. et al. Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model. PLoS One 2017; 12: e0181553
• 37 Thimme R, Heim M, Baumert TF. et al. Hepatitis B and C: From molecular virology to new antiviral therapies (part 1). Dtsch Med Wochenschr 2014; 139: 655-659
• 38 Thimme R, Heim M, Baumert TF. et al. Hepatitis B and C: from molecular virology to new antiviral therapies (part 2). Dtsch Med Wochenschr 2014; 139: 778-782
• 39 Thoma C, Hasselblatt P, Kock J. et al. Generation of stable mRNA fragments and translation of N-truncated proteins induced by antisense oligodeoxynucleotides. Mol Cell 2001; 8: 865-872
• 40 von Weizsäcker F, Kock J, Wieland S. et al. Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis. Hepatology 1999; 30: 308-315
• 41 von Weizsäcker F, Pult I, Geiss K. et al. Selective transmission of variant genomes from mother to infant in neonatal fulminant hepatitis B. Hepatology 1995; 21: 8-13
• 42 von Weizsäcker F, Wieland S, Blum HE. Inhibition of viral replication by genetically engineered mutants of the duck hepatitis B virus core protein. Hepatology 1996; 24: 294-299
• 43 Wagner D, Kern WV. Tuberculosis and nontuberculous mycobacterial infections. Dtsch Med Wochenschr 2011; 136: 691-694
• 44 Wagner D, Vos M, Buiting AG. et al. "Mycobacterium tilburgii" infections. Emerg Infect Dis 2006; 12: 532-534
• 45 Walter E, Keist R, Niederost B. et al. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996; 24: 1-5